相关实验视频
Updated: May 17, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
16.5K
延迟过敏对皮肤莱什曼病的内侧膜抗体的延迟过敏
Owain Donnelly1,2, Anna M Checkley1,2, Stephen L Walker1,2,3
1Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
The American journal of tropical medicine and hygiene
|October 23, 2025
概括
皮肤莱什曼病 (CL) 治疗时使用内溶性梅格胺抗酸可引起过敏反应. 这一案例突出了I型和IV型混合过敏症,促使停止治疗并最终解决病变.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 内溶性五价抗金药是皮肤雷什曼病 (CL) 的标准治疗方法.
- 对抗氧药物可能出现不良反应,包括过敏症.
- 了解这些反应对于患者管理至关重要.
研究的目的:
- 报告在CL治疗期间对梅格卢明抗酸过敏反应的病例.
- 审查有关抗氧化物药物过敏的文献.
- 提高临床医生对这种潜在不良影响的认识.
主要方法:
- 一个61岁的男性被诊断出患有CL的病例报告.
- 通过组织学和PCR证实了诊断.
- 治疗内伤性大光抗酸盐的治疗.
- 监测不良事件和临床反应.
主要成果:
- 患者在注射梅格胺抗酸后出现局部胀,红血和疹.
- 怀疑是I型和IV型混合过敏反应.
- 治疗被停止,CL病变在36个月内自发消失.
结论:
- 对损伤内抗生素的过敏反应是CL治疗中的潜在并发症.
- 临床医生应警过敏反应,并考虑替代疗法.
- 需要进一步研究抗氧化剂过敏症的流行率和治疗方法.
相关概念视频
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

